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Abstract 
Carnitine preferentially stimulates the basal and calcium-ionophore (A23187)-stimulated synthesis and 
release of 6-keto-PGFl~ from carrageenin-elicited peritoneal macrophages x-vivo. 
Introduction 
L-carnitine (fl-hydroxy-(-N-trimethylammonio)- 
butyrate) is a natural amino acid which is essential 
for the transport of long chain fatty acids into 
mitochondria for fl-oxidation [1]. Recently carnitine 
has been shown to enhance the formation of arachi- 
donic acid (AA) from linoleic acid by isolated hep- 
atocytes and to inhibit human neutrophil superox- 
ide production [2, 3]. As cyclooxygenase (CO) and 
lipoxygenase (LO) metabolites of AA (eicosanoids) 
are important modulators of macrophage func- 
tions, including superoxide production, [4] we in- 
vestigated the possibility that L-carnitine could 
also modulate macrophage eicosanoid synthesis. 
Materials and methods 
Male Wistar rats (16 weeks, four rats/group) were 
given 300 mg carnitine/kg dissolved in 1 ml dis- 
tilled water, or distilled water alone, by intubation 
on days 1-4. On day i all animals were injected 
with 2 ml of a carrageenin solution (1 mg/ml) in- 
traperitoneally. On day 4, 1 h after the last admin- 
istration of carnitine, the macrophages were iso- 
lated from pooled peritoneal washes by density 
gradient centrifugation and suspended at 2 x 10  6 
nucleated cells/ml in Dulbecco's modified Eagle's 
medium. Portions (1 ml) of the macrophage prepa- 
ration were incubated at 37 ~ for either 2 h (basal 
release) or for 30rain with 10-VM A23187 
(ionophore-stimulated r lease). The cells were then 
centrifuged and the supernatant fractions analysed 
for thromboxane (TX) A 2 (analysed as TXB2) 
prostaglandin (PG) E z, prostacyclin (PGIz) 
(analysed as 6 keto-PGFt~) and leukotriene (LT) 
B 4 by radioimmunoassay. 
In other experiments carrageenin-elicited macro- 
phages from control rats were incubated with car- 
nitine for 2 h or 24 h. The supernatant fractions 
were also analysed for eicosanoids. 
Results 
Carnitine significantly (p<0.005) reduced the 
number of macrophages i olated 4 d after an in- 
traperitoneal injection of carrageenin: control 
40 _+ 11, carnitine 19 + 6 (Values are mean __ SD; 
X 106; n = 3). 
The basal synthesis and release of PGE2, 6 keto- 
PGFI~ and LTB4 was stimulated by carnitine treat- 
ment. In contrast, TXB 2 formation was inhibited 
(Table 1). As a result he 6 keto-PGF1, : TXB 2 ratio 
increased (control ratio 0.22; carnitine ratio 0.86). 
A23187 stimulated the release of the four ei- 
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Table 1 
The effect of carnitine on the basal and A23187-stimulated re 
lease of eicosanoids from carrageenin elicited rat peritoneal 
macrophages. Eicosanoid synthesis and release (ng/2 x106 nucle- 
ated cells) 
Eicosanoid Control A23187(10 -sM) 
Control Carnitine Control Carnitine 
TXB 2 5.09 2.86* 7.28 8.13 
6-keto-PGF1, 1.19 2.26 * 4.95 22.26 *
PGEz 1.05 1.50 * 3.75 3.58 
LTB 4 0.065 0.104" 0.838 1.644" 
Mean values were significantly different from the corresponding 
control values (Mann-Whitney U-test): *p < 0.05. 
cosanoids assayed. Synthesis of 6 keto-PGF~ and 
LTB 4 was further enhanced by carnitine, There 
was no effect on PGE2 or TXB2 formation. In the 
presence of A23187 there was a preferential in- 
crease in 6 keto-PGF1, synthesis, relative to both 
TXB 2 (control ratio 1.02; carnitine ratio 4.95) and 
LTB4, (A23187 control ratio 6.70; A23187+ 
carnitine 15.19) (Table 1). 
Carnitine had no effect on macrophage eicosanoid 
release during incubations of 2 h or 24 h, (values 
not shown). 
Discussion 
The results presented here clearly show that the 
acute oral administration f carnitine modified the 
ability of macrophages to synthesize icosanoids. 
It is not clear what mechanisms are involved. No 
changes in LDH or eicosanoid release were de- 
tected after incubating macrophages with carnitine 
in vitro (data not presented) so that it would ap- 
pear unlikely that carnitine acted indirectly by 
damaging the macrophages or directly by stimulat- 
ing phospholipase, CO or LO activities. It is possi- 
ble that carnitine stimulated AA formation [2] but 
that we did not detect his in vitro because we in- 
cubated our macrophages in a serum free medium. 
Of particular interest is the finding that carnitine 
treatment increased the 6 keto-PGFl~: TXB 2 ratio, 
(basal and A23187-stimulated) and 6 keto- 
PGFI~:LTB4 ratio (A23187-stimulated). A de- 
crease in the PGI z : TXA 2 ratio is thought o be an 
important factor in the progression of some car- 
diovascular diseases [5] while the stimulatory effect 
of LTs are only maximally observed in the absence 
of CO products [6]. Thus, changes in eicosanoid 
ratios induced by feeding carnitine could have im- 
portant implications for regulation of inflamma- 
tory events in general. This concept is supported 
by the finding that cell infiltration into the peri- 
toneum, in response to chemotactic stimuli in- 
duced by carrageenin, was reduced by carnitine 
treatment. This fact, together with the report that 
carnitine inhibits neutrophil superoxide produc- 
tion [3], suggests that carnitine could be anti-in- 
flammatory in vivo. 
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